Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease

被引:28
作者
Hiki, Makoto [1 ]
Shimada, Kazunori [1 ]
Ohmura, Hirotoshi [1 ]
Kiyanagi, Takashi [1 ]
Kume, Atsumi [1 ]
Sumiyoshi, Katsuhiko [1 ]
Fukao, Kosuke [1 ]
Inoue, Nao [1 ]
Mokuno, Hiroshi [1 ]
Miyazaki, Tetsuro [1 ]
Daida, Hiroyuki [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138421, Japan
关键词
Coronary artery disease; Lipoproteins; LDL; MALONDIALDEHYDE-MODIFIED LDL; APO A-I; HEART-DISEASE; MYOCARDIAL-INFARCTION; PLAQUE INSTABILITY; METABOLIC SYNDROME; PLASMA; RISK; PREDICTOR; EVENTS;
D O I
10.1016/j.jjcc.2008.09.010
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Oxidized tow-density lipoprotein (OxLDL) and remnant lipoprotein play a crucial role in the development of atherosclerosis. Recently, a novel method for measuring remnant cholesterol levels (remnant lipoproteins cholesterol homogenous assay: RemL-C) has been established. However, the correlation between OxLDL and remnant lipoprotein, including RemL-C, has not been fully investigated. Methods: We enrolled 25 consecutive patients with documented coronary artery disease (CAD) and 20 controls. Remnant-like particle cholesterol (RLP-C) and RemL-C were used to determine the levels of remnant lipoprotein cholesterol. Serum levels of malondialdehyde-modified LDL (MDA-LDL) and OxLDL using a monoclonal antibody DLH3 (OxPC) were used to measure the concentration of circulating OxLDL. Results: The CAD group had high levels of fasting glucose and glycosylated hemoglobin (HbA1c), and tow levels of high-density lipoprotein cholesterol compared with the control group. Serum levels of total cholesterol or LDL cholesterol were not significantly different between the two groups. The levels of RemL-C (p = 0.035), MDA-LDL (p = 0.018), and MDA-LDL/LDL-C (p = 0.036) in the CAD group were significantly higher than those in the control group. The levels of RLP-C tended to be higher in the CAD group than those in the control group (p = 0.096). Positive correlations were demonstrated between remnant lipoprotein cholesterol and OxLDL (RLP-C and MDA-LDL/LDL-C, r = 0.45, p = 0.0024, RLP-C and OxPC, r = 0.51, p = 0.0005, RemL-C and MDA-LDL/LDL-C, r = 0.42, p = 0.0044, RemL-C and OxPC, r = 0.43, p = 0.0043). Similar trends were observed in non-diabetic subjects and in subjects without metabolic syndrome. Positive correlations were also observed between RLP-C and RemL-C (r = 0.94, p < 0.0001) and between MDA-LDL/LDL-C and OxPC (r = 0.40, p = 0.0074). Conclusions: These results suggest that the association between high levels of remnant lipoprotein cholesterol and high OxLDL levels might be linked to atherogenesis in patients with CAD. (c) 2008 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:108 / 116
页数:9
相关论文
共 43 条
[1]
[Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794
[2]
Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease [J].
Eberly, LE ;
Stamler, J ;
Neaton, JD .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (09) :1077-+
[3]
Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases [J].
Ehara, S ;
Ueda, M ;
Naruko, T ;
Haze, K ;
Matsuo, T ;
Ogami, M ;
Ikura, Y ;
Itabe, H ;
Komatsu, R ;
Yoshiyama, M ;
Takeuchi, K ;
Yoshikawa, J .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2002, 16 (01) :60-64
[4]
Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes [J].
Ehara, S ;
Ueda, M ;
Naruko, T ;
Haze, K ;
Itoh, A ;
Otsuka, M ;
Komatsu, R ;
Matsuo, T ;
Itabe, H ;
Takano, T ;
Tsukamoto, Y ;
Yoshiyama, M ;
Takeuchi, K ;
Yoshikawa, J ;
Becker, AE .
CIRCULATION, 2001, 103 (15) :1955-1960
[5]
The metabolic syndrome and antioxidant concentrations - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Mokdad, AH ;
Giles, WH ;
Brown, DW .
DIABETES, 2003, 52 (09) :2346-2352
[6]
Fredrikson GN, 2003, J INTERN MED, V253, P425, DOI 10.1046/j.1365-2796.2003.01128.x
[7]
New risk factors for atherosclerosis and patient risk assessment [J].
Fruchart, JC ;
Nierman, MC ;
Stroes, ESG ;
Kastelein, JJP ;
Duriez, P .
CIRCULATION, 2004, 109 (23) :15-19
[9]
Havel Richard J., 1994, Current Opinion in Lipidology, V5, P102, DOI 10.1097/00041433-199404000-00006
[10]
Hitsumoto Takashi, 2006, J Cardiol, V48, P65